| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Alendronate | FAERS: 7 | US FAERS | |
| 2 | Isotretinoin | FAERS: 3 | US FAERS | |
| 3 | Buprenorphine | FAERS: 2 | OFFSIDES US FAERS | |
| 4 | Fingolimod Hydrochloride | FAERS: 2 | US FAERS | |
| 5 | Pregabalin | FAERS: 2 | US FAERS | |
| 6 | Arthrotec | FAERS: 1 | US FAERS | |
| 7 | Letrozole | FAERS: 1 | US FAERS | |
| 8 | Pramipexole | FAERS: 1 | US FAERS | |
| 9 | Quetiapine Fumarate | FAERS: 1 | US FAERS | |
| 10 | Rosiglitazone | FAERS: 1 | US FAERS | |
| 11 | Tadalafil | FAERS: 1 | US FAERS | |
| 12 | Vitamin B 12 | FAERS: 1 | US FAERS | |
| 13 | carfilzomib | FAERS: 1 | US FAERS | |
| 14 | lanreotide | FAERS: 1 | US FAERS | |
| 15 | ledipasvir, sofosbuvir drug combination | FAERS: 1 | US FAERS | |
| 16 | ropinirole | FAERS: 1 | US FAERS | |
| 17 | Docusate sodium | OFFSIDES | ||
| 18 | Tretinoin | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.